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SYNOPSIS 
 
The thesis entitled “Total synthesis of Hyacinthacine A1, (-)-Epiquinamide 
and Synthetic approach towards non-peptide part of Celebeside A and C” has been 
divided into three chapters.  
 
CHAPTER-I : Chapter I describes the “Total synthesis Hyacinthacine A1”. 
 
CHAPTER-II :Chapter II describes the “Total synthesis of (-)-
Epiquinamide”. 
 
CHAPTER-III : Chapter III describes the “Synthetic approach towards non- 
peptide part of Celebeside A and C”. 
 
 
CHAPTER-I 
This chapter describes “Total synthesis of hyacinthacine A1” 
 
The good biological profile offered by polyhydroxylated pyrrolizidine class of 
alkaloids, natural scarcity and as a part of our ongoing project on synthesizing 
iminosugars, a practical and enantioselective total synthesis of natural hyacinthacine A1 
is achieved. Hyacinthacine A1, isolated from bulbs of Muscari armeniacum, is a potent 
inhibitor of lactase, moderate inhibitor of amyloglucosidase and α-fucosidase. The key 
steps involved in this synthetic approach are syn allylic epoxide opening with retention 
using Pd catalysis and “domino” hydrogenation sequences to construct bicyclic lactam 
moiety. 
Retrosynthetic analysis of hyacinthacine A1 
 
The retrosynthetic strategy followed in the present work for the synthesis of 
hyacinthacine A1 is summarized in Scheme 1. The hyacinthacine A1 1 could be 
achieved from bicyclic lactam 2 which is accessible by reductive hydrogenation 
followed by cyclization of key intermediate azido alcohol 3 which could be achieved 
from syn-opening of α, β-unsaturated γ, δ-epoxy ester 4 by Miyashita’s approach. The 
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intermediate 4 accessible from the aldehyde 5 which could in turn be achieved from the 
L-(+)-diethyl tartrate. 
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Synthesis of allylic alcohol 11 
 
Commercially available L-(+)-diethyl tartrate 6 was subjected to benzylidine 
protection in benzene using PTSA to furnish the benzylidine acetal 7 in 67% yield. The 
benzylidine acetal cleavage was achieved using LAH-AlCl3 combination in anhydrous 
Et2O afforded the benzyloxy triol 8 in 74% as a white solid. The isopropylidine 
protection of 1, 2-diol in 8 with 2, 2-DMP in CH2Cl2 at 0 
oC – room temperature 
afforded the isopropylidine ketal 9 in 90 % yield. The primary alcohol functionality in 9 
was oxidized to aldehyde 5 with IBX in EtOAc under reflux condition. The aldehyde 
was subjected to two-carbon homologation with a stable Wittig ylide 
ethoxycarbonylmethylene triphenylphosphorane to furnish (E)-α, β-unsaturated ester 
10. Chemoselective reduction of ester functionality in the presence of double bond was 
achieved with DIBAL-H at 0 oC to furnish the allylic alcohol 11 in 96% yield (scheme 
2). 
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Synthesis of azide compound 14 
Allylic alcohol 11 was subjected to Sharpless asymmetric epoxidation under 
standard conditions using D-(-)-DET, TBHP and Ti(OiPr)4 afforded the chiral epoxy 
alcohol 12.  
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IBX oxidation of epoxy alcohol in reflux condition in EtOAc afforded the 
epoxy aldehyde 13. The epoxy aldehyde upon two-carbon homologation using 
ethoxycarbonylmethylene triphenylphosphorane in benzene furnished the (E) - α, β-
unsaturated γ, δ-epoxy ester 4 (separable E/Z: 95/5, by 1H NMR and HPLC). Now the 
stage is set ready for next crucial reaction. The desired azido group was introduced with 
retention of configuration taking advantage of neighboring conjugated olefin group via 
π-allyl Pd-complex followed by double inversion.  The protection of syn-azido alcohol 
as MOM ether 14 was achieved using MOMCl and DIPEA (scheme 3). 
 
Completion of synthesis of hyacinthacine A1 
The selective acidic hydrolysis of isopropylidine group in the presence of MOM 
ether using PPTS in MeOH realized the diol 15 in 74 % yield. The selective blocking of 
primary alcohol was achieved under silylation conditions (TBSCl, Imidazole) to realize 
the TBS ether 16. The prerequisite for the most critical domino reaction to generate 
bicyclic pyrrolizidone moiety was to make the free secondary alcohol as mesyl ester by 
exposing 16 to MsCl, Et3N. The resulting mesylate 17 when subjected to hydrogenation 
(10% Pd-C, H2) followed by filtration, and the filtrate was refluxed in presence of 
K2CO3 resulting in a cascade of transformations which include reduction of azide to 
amine followed by a SN2 displacement of mesylate to generate the pyrrolidine 
intermediate, which in turn underwent an intramolecular amidation with the ester to 
furnish pyrrolizidone 2 in 65% yield. The concomitant olefin reduction and 
hydrogenolysis of benzyl ether was obvious. The bicyclic lactam 2 upon acidic 
hydrolysis with PTSA and CSA (cat.) afforded the lactam triol 19 which was not 
isolated but after reduction of amide functionality with LiAlH4 achieved hyacinthacine 
A1 1. It was fully characterized by 
1H NMR, 13C NMR, ESIMS, HRMS, IR and specific 
rotation (scheme 4). 
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In conclusion, the total synthesis of hyacinthacine A1 is achieved starting from 
readily commercially available L-(+)-DET. The key steps are the azido group 
introduction with retention of configuration while opening epoxide and the domino-
pyrrolizidone construction in one stroke. 
 
CHAPTER-II 
 
This chapter describes “Total synthesis of (-)-Epiquinamide” 
As part of a programme aimed at building a natural product library with alkaloid 
scaffolds as the backbone, we desired an efficient route to larger quantities of key 
natural products and also their intermediates. With this programme, we develoved a 
practical synthesis of epiquinamide following the retrosynthetic planning shown in 
scheme 1. We have devised the plan in such a way that by changing the specific chiral 
reagent (ADmix α or ADmix β) while following the same synthetic route, will be able 
to synthesize both the enantiomers of epiquinamide. The key steps included are, the 
propargyl alcohol rearrangement to all trans-diene ester, Sharpless asymmetric 
dihydroxylation and one-pot reduction-lactamization. 
Retrosynthetic analysis of epiquinamide enantiomers. 
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The retrosynthetic strategy followed in the present work for the synthesis of 
epiquinamide enantiomers is summarized in scheme 1. The (-)-epiquinamide 1a could 
be obtained by azidation-reduction-acetylation of 2a which could in turn be obtained 
from intramolecular reductive lactamization of 3a. The intermediate 3a could be 
obtained by lactonization and azidation of 4a which could in turn be accessed by 
Sharpless dihydroxylation of 5. The conjugated diene ester 5 obtained by a propargyl 
alcohol rearrangement of the alkynol from commercially available hexane-1, 6-diol 6. 
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Synthesis of α, β-unsaturated γ, δ-dihydroxy ester 
 The synthesis began with the commercially available hexane-1, 6-diol 6 which 
was subjected to mono-TBS protection in CH2Cl2 at 0 
oC followed by oxidation of 
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alcohol with bis(acetoxy)iodobenzene (BAIB)-2,2,6,6-tetramethylpiperidine-N-oxide 
(TEMPO) afforded the aldehyde 8. The aldehyde 8 was subjected to next crucial step to 
append the ethyl propiolate group. The lithiated ethyl propiolate on addition with 
aldehyde 8 produced the racemic alkynol 9 in 77% yield.  
 
 TBSCl, Imidazole
        CH2Cl2
OH
TBSO
CHO
4
OH
CO2Et
BAIB, TEMPO
       CH2Cl2
CO2Et, LiHMDS
THF, -78 oC, 30 min
             77%
TBSO
CO2Et
PPh3, benzene
      CH3SO2NH2
tBuOH : H2O (1 : 1)
 0 oC, 3 days, 80%
TBSO
CO2Et
OH
OH
6
8
9
5
OTBS rt, 6 h, 84 %
4a
HO TBSO
OH
7
AD mix α
TBSO
CO2Et
OH
OH4b
AD mix
30 min, 0 oC, 75% 0 oC to rt, 2 h, 92%
scheme 2
β 
 
 
Thus following Guo et al protocol alkynol in presence of PPh3 in benzene 
afforded the (E, E)-diene ester 5 which is the common precursor for the synthesis of 
both the epiquinamide enantiomers. The diene ester 5, being the common precursor for 
the synthesis of both the enantiomers of epiquinamide, was subjected to 
dihydroxylation using the combination ADmix α-methane sulfonamide or ADmix β-
methane sulfonamide in tBuOH:H2O (1:1) following the Sharpless asymmetric 
dihydroxylation protocol yielded the diol 4a and 4b independently. The diols 4a and 
4b, being the enantiomers, showed the same charactrization datas with oposite specific 
rotation values (scheme 2). 
 
 
Synthesis of azide 13a 
Diol 4a, being the intermediate of requirement to synthesize mesyl azide 13a, 
was subjected to catalytic hydrogenation with Pd-C, H2 in EtOAc and then refluxed 
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with K2CO3 in THF to achieve the butyrolactone 10a.
 The secondary hydroxyl group in 
butyrolactone 10a was transformed to the azido group via tosylate 11a to realize the 
azide 3a. As the stage is set for building quinolizine framework, the silyl ether 3a was 
transformed to mesyl ester 13a via the azido alcohol 12a (scheme 3). 
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Completion of synthesis of (-)-epiquinamide 
The mesylate 13a was subjected to one-pot reduction-double cyclization 
involving azide reduction to amine which underwent intramolecular cyclization 
displacing mesylate. Another facile lactamization opened up the butyrolactone ring to 
furnish the hydroxyl quionolizidione 2a in 55% yield. The hydroxyl lactam 2a was 
mesylated with mesyl chloride, Et3N in CH2Cl2 to furnish mesyl ester 14a in 100% 
yield. The mesyl ester 14a was subjected to azidation through a SN2 substitution by 
heating with NaN3 in DMF at 65 
oC for 36h yielding a separable mixture of azide 16a 
(50%) and subsequent elimination product 15a (20%) which increased upon prolong 
heating at same temperature or higher temperature. LiAlH4 mediated reduction of 
lactam amide and azide in THF in reflux condition followed by acetylation of its free 
amine achieved the (-)-epiquinamide 1a which was fully characterized by its PMR, 13C 
NMR, ESIMS, HRMS, IR and specific rotation value (scheme 4). 
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Synthesis of opposite enantiomer of 16a 
Following the same reaction sequences followed for 4a, 16b (the intermediate 
for synthesis of (+)-epiquinamide) was synthesized starting from 4b as shown in 
scheme 5.  
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In conclusion, asymmetric total synthesis of (-)-epiquinamide and the 
intermediate for synthesis of (+)-epiquinamide have been achieved starting from 
commercially available 1, 6-hexane-diol using propargyl alcohol rearrangement to all 
trans-diene ester, Sharpless asymmetric dihydroxylation and one-pot reduction 
lactamization. 
 
CHAPTER-III 
 
This chapter describes “Synthetic approach towards the non-peptide 
part of Celebeside A and C” 
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The novel biological profile being offered by cyclic depsipeptides, its natural 
scarcity, depsipeptides architecture and as a part of our ongoing project on synthesizing 
cyclic peptide and depsipeptides with their biological study, encouraged us to attempt 
the synthetic approach towards celebeside A 1 (anti-HIV activity). In the present work, 
we have synthesized the non-peptide part 2 which is common to both celebeside A and 
C. Regioselective opening of cis-epoxy alcohol, Evans syn aldol and propargyl alcohol 
rearrangement to all trans-diene ester are the key steps included in the present 
synthesis.  
Retrosynthetic analysis: 
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The retrosynthesis of this marine natural product is based on the strategy as 
shown in scheme 1. 
Celebeside A 1 synthesized mainly from three fragments 2, 3 and 4. As seen in 
scheme 1, fragments 3 and 4 could be achieved from the naturally occurring amino 
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acids and D-threonine 12 and (R)-3-amino-2-hydroxypropanoic acid 11. Fragment 2 
which is the common non-peptide part of both celebeside A and C could be achieved 
through Evans syn aldol protocol from chiral auxiliary 6 and aldehyde 5 which could be 
synthesized from cis-butene-1, 4-diol 7 (scheme 1). 
Synthesis of diol 17 
Synthesis was begun with commercially available cis-butene-1, 4-diol 7 which 
was protected as its mono benzyl ether in THF at room temperature yielded 13 in 73% 
yield. The allylic alcohol 13 was subjected to Sharpless asymmetric epoxidation using 
L-(+)-DET, Ti(OiPr)4, TBHP, at -25 
oC in CH2Cl2 to furnish the chiral epoxy alcohol 
14 in 80% isolated yield.  
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The regioselective opening of chiral epoxy alcohol 14 with Me3Al in n-pentane 
and CH2Cl2 from -10 
oC to rt afforded a mixture of 1, 2-diol (major) and 1, 3-diol 
(minor). The nucleophilic substitution reaction of 2, 3-epoxy-1-alkanol with Me3Al 
occurred at C3 position preferably than C2 psition and gave the inseparable mixture of 
C3 and C2 substitution product.The crude mixture was subjected to acetonide 
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protection in acetone with catalytic amount of PTSA at room temperautre and afforded 
the separable acetonides 16 and 15 in 9:1 ratio. Isopropylidine group cleavage in 16 
with PTSA in MeOH afforded the diol 17 (scheme 2). 
 
Synthesis of Evans aldol adduct 21  
Selective silylation of primary alcohol with TBDPSCl, imidazole in CH2Cl2 
gave TBDPS ether 18 in 90% yield. The secondary free hydroxyl group was protected 
as its MOM ether by MOMCl, DIPEA in CH2Cl2 at -10 
oC to room temperautre to 
furnish the MOM ether 19. The MOM ether 19 underwent a smooth cleavage of benzyl 
group in catalytic hydrogenation condition with Pd(OH)2 in EtOH to furnish the alcohol 
20 in 91% yield. The alcohol upon IBX oxidation in THF-DMSO at room temperautre 
furnished aldehyde 5 in 82% yield. The aldehyde was subjected to Evans syn alodol 
reaction with propanoyl oxazolidinone 6 using TiCl4 (1.0 eq), (-)-sparteine (2.5 eq) at -
78 oC to furnish the Evans syn aldol adduct 21 in 73% isolated yield and 90% de 
(scheme 3). 
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Synthesis of alcohol 26 
 
Silyl protection of the secondary hydroxyl group as TBS ether with TBSOTf 
and DIPEA in CH2Cl2 gave TBS ether 22 in 97% yield. The reductive removal of chiral 
auxiliary with LiBH4 in ether and water (cat.) at 0 
oC afforded the free alcohol 23 in 
81% isolated yield.  
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The IBX oxidation of the primary alcohol 23 followed by two-carbon 
homologation using ethyl triphenylphosphonium iodide salt and n-BuLi furnished the 
olefin 25 via the aldehyde 24. Selective desilylation of primary TBDPS ether in the 
presence of secondary TBS ether was achieved by use of NH4F (excess) in methanol 
under reflux condition for 24h to furnish the primary alcohol 26 (scheme 4). 
Synthesis of non-peptide fragment 2 
IBX oxidation of primary alcohol 26 followed by two-carbon homologation 
with ethoxycarbonylmethylene triphenylphosphorane in CH2Cl2 afforded exclusively α, 
β-unsaturated ester 28 in 95% isolated yield via the aldehyde 27. Saturation of olefin 
functionalities by catalytic hydrogenation using 10% Pd-C smoothly delivered the 
corresponding saturated ester 29 in 100% yield. Then ester functionality was reduced 
with LiBH4 in EtOH-THF to afford the primary alcohol 30 in 91% yield. 
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The IBX oxidation of primary alcohol 30 afforded the aldehyde which was very 
unstable and it was not characterized. The aldehyde was subjected to next crucial step 
to append the ethyl propiolate group. The lithiated ethyl propiolate on addition with 
aldehyde produced the alkynol 31 in 81% isolated yield. The alkynol, which is the 
propargylic alcohol, suitably set the stage ready for deoxygenation-isomerization 
through “allene”-type rearrangement in the presence of PPh3. Thus following Guo et al 
protocol, alkynol 31 in the presence of PPh3 in benzene afforded the (E,E)-diene ester 
29 in 70% isolated yield. The diene ester 2 was fully characterized with PMR, 13C 
NMR, ESIMS, HRMS, IR and specific rotation value (scheme 5). 
 
In conclusion, the non-peptide part of the celebeside A and C was achieved 
starting from the cheaply and readily commercially available cis-2-butene-1, 4-diol 
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using Me3Al mediated regioselective opening of syn-epoxy alcohol, Evans syn aldol 
and alkynol rearrangement to all trans-diene ester as the key steps. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
